| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-08 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.68 | 4e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |